Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherence
Little is known about the impact of genetic and environmental risk assessment (GERA) feedback on colorectal cancer (CRC) screening. In a recently completed randomized trial, primary care patients received GERA feedback based on a blood test for genetic polymorphisms and serum folate level (GERA Group) versus usual care (Control Group). Subsequently, participants were offered CRC screening. Among participants who received GERA feedback, being at elevated risk was negatively associated with prospective CRC screening adherence. Secondary analyses of data from this study were performed to identify independent predictors of adherence among participants who received GERA feedback. We obtained baseline survey, follow-up survey, and endpoint medical records data on sociodemographic background, knowledge, psychosocial characteristics, risk status, and adherence for 285 GERA Group participants. Univariate and multivariable analyses were performed to identify predictors of CRC screening adherence. Following a 6-month outcomes observation period, we also conducted two focus groups with GERA Group participants to assess their perceptions of GERA risk feedback and screening. Content analyses of focus group data were evaluated to gain insights into participant response to risk feedback. Overall, half of GERA Group participants adhered to screening within 6 months after randomization. Multivariable analyses showed a statistically significant interaction between race and GERA feedback status relative to screening adherence (p = 0.043). Among participants who received average risk feedback, adherence was comparable among whites (49.7 %) and nonwhites (54.1 %); however, among those at elevated risk, adherence was substantially higher among whites (66.7 %) compared to nonwhites (33.3 %). Focus group findings suggest that whites were more likely than nonwhites to view elevated risk feedback as a prompt to screen. In response to receiving elevated risk feedback, nonwhites were more likely than whites to report feeling anxiety about the likelihood of being diagnosed with CRC. Further research is needed to explore race-related CRC screening differences in response to GERA feedback.
KeywordsGenetic Environment Risk assessment Cancer Colorectal Screening Adherence
The authors gratefully acknowledge the invaluable contributions of Anett Petrich, Heidi Swan, Thomas Wolf and members of the Fox Chase Cancer Center Genomics Facility. This research was supported by Grant R01 CA112230 and P30 CA006927 from the National Institutes of Health.
Conflict of interest
Ronald E. Myers, Karen Ruth, Sharon L. Manne, James Cocroft, Randa Sifri, Barry Ziring, Desiree Burgh, Eric Ross and David S. Weinberg declare that they have no conflict of interest.
Human and animal rights and Informed Consent
All procedures followed were in accordance with ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
- Baier, M., Calonge, N., Cutter, G., McClatchey, M., Schoentgen, S., Hines, S., … Ahnen, D. (2000). Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiology and Biomarkers Prevention, 9, 229–232.Google Scholar
- Cella, D., Hughes, C., Peterman, A., Chang, C. H., Peshkin, B. N., Schwartz, M. D., & Lerman, C. (2002). A brief assessment of concerns associated with genetic testing for cancer: The Multidimensional Impact of Cancer Risk Assessment (MICRA) Questionnaire. Health Psychology, 21, 564–572.CrossRefPubMedGoogle Scholar
- Croyle, R. T., Sun, Y. C., & Hart, M. (1997). Processing risk factor information: Defensive biases in health-related judgments and memory. In K. J. Petrie & J. A. Weinman (Eds.), Perceptions of health and illness (pp. 267–483). New York, NY: Overseas Publishers Association.Google Scholar
- Ghazarian, A. A., Simonds, N. I., Bennett, K., Pimentel, C. B., Ellison, G. L., Gillanders, E. M., … Mechanic, L. E. (2013). A review of NCI’s extramural grant portfolio: Identifying opportunities for future research in genes and environment in cancer. Cancer Epidemiology, Biomarkers & Prevention, 22, 501–507.Google Scholar
- Giovannucci, E., Stampfer, M. J., Colditz, G. A., Hunder, D. J., Fuchs, C., Rosner, B. A., … Willett, W. C. (1998). Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Annals of Internal Medicine, 129, 517–524.Google Scholar
- Hilgart, J., Phelps, C., Bennett, P., Hood, K., Brian, K., & Murray, A. (2010). “I have always believed I was at high risk…” The role of expectation in emotional responses to the receipt of an average, moderate or high cancer genetic risk assessment result: A thematic analysis of free-text questionnaire comments. Familial Cancer, 9, 469–477.CrossRefPubMedGoogle Scholar
- Keku, T, Millikan, R., Worley, K., Winkel, S., Eaton, A., Biscocho, L., … Sandler, R. (2002). 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiology, Biomarkers & Prevention, 11, 1611–1621.Google Scholar
- Kennedy, D. A., Stern, S. J., Matok, I., Moretti, M. E., Sarkar, M., Adams-Webber, T., et al. (2012). Folate intake, MTHFR Polymorphisms, and the risk of colorectal cancer: A systematic review and meta-analysis. Journal of Cancer Epidemiology, Article ID 952508.Google Scholar
- Ma, J., Stampfer, M. J., Giovannucci, E., Artigas, C., Hunter, D. J., Fuchs, C., … Rozen, R. (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Research, 57, 1098–1102.Google Scholar
- McBride, C. M., Koehly, L. M., Sanderson, S. C., & Kaphingst, K. A. (2010). The behavioral response to personalized genetic information: Will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annual Review of Public Health, 31, 89–103.CrossRefPubMedGoogle Scholar
- Myers, R. E., Bittner-Fagan, H., Daskalakis, C., Sifri, R., Vernon, S. W., Cocroft, J., & Andrel, J. (2013). A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening. Cancer Epidemiology, Biomarkers and Prevention, 22, 109–117.CrossRefPubMedGoogle Scholar
- Myers, R. E., Hyslop, T., Sifri, R., Bittner-Fagan, H, Katurakes, N., Crocroft, J., … Wolf, T. (2008). Tailored navigation in colorectal cancer screening. Medical Care, 46, S123–S131.Google Scholar
- Myers, R. E., Jepson, C., Ross, E., Jepson, C., Wolf, T., Balshem, A., … Leventhal, H. (1994). Modeling adherence to colorectal cancer screening. Preventive Medicine, 23, 142–151.Google Scholar
- Myers, R. E., Manne, S. L., Wilfond, B., Sifri, R., Ziring, B., Wolf, T., … Weinberg, D. S. (2011). A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: Trial design and baseline findings. Contemporary Clinical Trials, 32, 25–31.Google Scholar
- Myers, R. E., Sifri, R., Daskalakis, C., DiCarlo, M., Ramakrishnan Geethakumari, P., Cocroft, J., … Vernon, S. W. (2014). Increasing colon cancer screening in primary care among African Americans. Journal of the National Cancer Institute. doi: 10.1093/jnci/dju344.
- Myers, R. E., Sifri, R., Hyslop, T., Rosenthal, M., Vernon, S. W., Cocroft, J., … Wender, R. (2007). A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer, 110, 2083–2091.Google Scholar
- Palaniappan, L. P., Maxwell, A. E., Crespi, C. M., Wong, E. C., Shing, J., & Wang, E. J. (2011). Population colorectal cancer screening estimates: Comparing self-report to electronic health record data in California. International Journal of Cancer Research and Prevention, 4, 28540.Google Scholar
- Taioli, E., Garza, M. A., Ahn, Y. O., Bishop, D. T., Bost, J., Budai, B., … Little, J. (2009). Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: A HuGE-GSEC review. American Journal of Epidemiology, 15, 1207–1021.Google Scholar
- Turner, R. M. (1998). Adaptive reasoning for real-world problems: A schema-based approach. New York, NY: Psychology Press.Google Scholar
- Vernon, S.W., Bartholomew, L. K., McQueen, A., Bettencourt, J. L., Greisinger, A., Coan, S. P., … Myers, R. E. (2011). A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: Sometimes more is just the same. Annals of Behavioral Medicine, 41, 284–299.Google Scholar
- Weinberg, D. S., Myers, R. E., Keenan, E., Ruth, K., Sifri, R., Ziring, B., … Manne, L. (2014). Gene environment risk assessment and colorectal cancer screening in an average risk population: A randomized controlled trial. Annals of Internal Medicine, 151, 537–545.Google Scholar